PROM1 and glioblastoma: In order to assess the transduction efficiency of CD133-LV in vivo, we established intracranial human GBM xenografts (CD133 content: 71.7±8.7%, n = 3 tumors generated by injection of GBML20) in NOD.SCID mice.